2,458
Views
27
CrossRef citations to date
0
Altmetric
Reports

A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect

, , , , , , , , , , , , & show all
Pages 468-477 | Received 29 Sep 2015, Accepted 15 Dec 2015, Published online: 04 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Cheng Lei, Yanling Wu & Tianlei Ying. (2019) A ‘sandwich’ strategy promises functional cure of chronic hepatitis B. Expert Review of Precision Medicine and Drug Development 4:1, pages 1-2.
Read now
Xuan-Yi Wang & Yu-Mei Wen. (2018) A “sandwich” strategy for functional cure of chronic hepatitis B. Emerging Microbes & Infections 7:1, pages 1-3.
Read now

Articles from other publishers (25)

Yang Wang, Qiqi Li, Cheng Li, Cong Wang, Shijie Wang, Wenjie Yuan, Demin Yu, Ke Zhang, Bisheng Shi, Xiaomei Chen, Tiantian Liu, Zhenghong Yuan, Shuping Tong, Michael Nassal, Yu-Mei Wen & Yong-Xiang Wang. (2023) Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion. Gut, pages gutjnl-2023-330537.
Crossref
Yuxiang Zhao, Linchuan Gan, Dangjin Ke, Qi Chen & Yajuan Fu. (2023) Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy. Journal of Translational Medicine 21:1.
Crossref
Mathew Folaranmi Olaniyan, Musa Abidemi Muhibi, Tolulope Busayo Olaniyan & Phoebe Nwamaka Kanikwu. (2023) Envelope antibody HBeIgG and HBV DNA in HBeAg-seronegative young adults in Nigeria. Journal of Bio-X Research.
Crossref
Rani Burm, Freya Van Houtte, Lieven Verhoye, Ahmed Atef Mesalam, Sandra Ciesek, Philippe Roingeard, Heiner Wedemeyer, Geert Leroux-Roels & Philip Meuleman. (2023) A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection. JHEP Reports 5:3, pages 100646.
Crossref
David Durantel. (2023) Therapies against chronic hepatitis B infections: The times they are a-changin’, but the changing is slow!. Antiviral Research 210, pages 105515.
Crossref
Saket Jhajharia, Fritz Lai, Heng Boon Low, Kiren Purushotorman, Bhuvaneshwari D/O Shunmuganathan, Conrad En Zuo Chan, Rachel Hammond, Hans-Jürgen Netter, Qingfeng Chen, Seng Gee Lim & Paul A. MacAry. (2022) Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus. npj Vaccines 7:1.
Crossref
Binfan Chen, Yuchen Chen, Jian Li, Chunyu Wang, Wenping Song, Yumei Wen, Jinzhong Lin, Yanling Wu & Tianlei Ying. (2022) A Single Dose of Anti-HBsAg Antibody-Encoding mRNA-LNPs Suppressed HBsAg Expression: a Potential Cure of Chronic Hepatitis B Virus Infection. mBio 13:4.
Crossref
Yang Wang, Wenjie Yuan, Siqi Guo, Qiqi Li, Xiaomei Chen, Cheng Li, Qianying Liu, Lei Sun, Zhenguo Chen, Zhenghong Yuan, Cheng Luo, Shijie Chen, Shuping Tong, Michael Nassal, Yu-Mei Wen & Yong-Xiang Wang. (2022) A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments. Nature Communications 13:1.
Crossref
Yanling Wu, Quanxiao Li, Yu Kong, Zhi Wang, Cheng Lei, Ji Li, Lulu Ding, Chunyu Wang, Yaping Cheng, Yaozhu Wei, Yuanlin Song, Zhenlin Yang, Chao Tu, Yu Ding & Tianlei Ying. (2022) A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors. Molecular Therapy 30:8, pages 2785-2799.
Crossref
Yingying Song, Shuyu Shou, Huimin Guo, Zixiang Gao, Nannan Liu, Yang Yang, Feifei Wang, Qiang Deng, Jing Liu & Youhua Xie. (2022) Establishment and characterization of a new cell culture system for hepatitis B virus replication and infection. Virologica Sinica 37:4, pages 558-568.
Crossref
Maxime Beretta & Hugo Mouquet. (2022) Advances in human monoclonal antibody therapy for HBV infection. Current Opinion in Virology 53, pages 101205.
Crossref
Shuqin Gu, Zhipeng Liu, Li Lin, Shihong Zhong, Yanchen Ma, Xiaoyi Li, Guofu Ye, Chunhua Wen, Yongyin Li & Libo Tang. (2021) Identification and Mapping of HBsAg Loss-Related B-Cell Linear Epitopes in Chronic HBV Patients by Peptide Array. Frontiers in Immunology 12.
Crossref
Yuanzhi Chen, Xinchu Xiang, Ruoyao Qi, Yiwen Wang, Yang Huang, Min You, Yangfei Xian, Yangtao Wu, Rao Fu, Ciming Kang, Jixian Tang, Hai Yu, Tianying Zhang, Quan Yuan, Wenxin Luo & Ningshao Xia. (2021) Novel monkey mAbs induced by a therapeutic vaccine targeting the hepatitis B surface antigen effectively suppress hepatitis B virus in mice. Antibody Therapeutics 4:4, pages 197-207.
Crossref
Qiao Wang, Eleftherios Michailidis, Yingpu Yu, Zijun Wang, Arlene M. Hurley, Deena A. Oren, Christian T. Mayer, Anna Gazumyan, Zhenmi Liu, Yunjiao Zhou, Till Schoofs, Kai-hui Yao, Jan P. Nieke, Jianbo Wu, Qingling Jiang, Chenhui Zou, Mohanmmad Kabbani, Corrine Quirk, Thiago Oliveira, Kalsang Chhosphel, Qianqian Zhang, William M. Schneider, Cyprien Jahan, Tianlei Ying, Jill Horowitz, Marina Caskey, Mila Jankovic, Davide F. Robbiani, Yumei Wen, Ype P. de Jong, Charles M. Rice & Michel C. Nussenzweig. (2020) A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations. Cell Host & Microbe 28:2, pages 335-349.e6.
Crossref
Bisheng Shi, Yanling Wu, Chunyu Wang, Xiaofang Li, Fan Yu, Bin Wang, Zhenlin Yang, Jianhua Li, Mifang Liang, Yumei Wen, Tianlei Ying & Zhenghong Yuan. (2019) Evaluation of antiviral - passive - active immunization (“sandwich”) therapeutic strategy for functional cure of chronic hepatitis B in mice. eBioMedicine 49, pages 247-257.
Crossref
Binbin Hong, Yumei Wen & Tianlei Ying. (2019) Recent Progress on Neutralizing Antibodies against Hepatitis B Virus and its Implications. Infectious Disorders - Drug Targets 19:3, pages 213-223.
Crossref
Zhiyong Ma, Ejuan Zhang, Shicheng Gao, Yong Xiong & Mengji Lu. (2019) Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response. Frontiers in Immunology 10.
Crossref
Dan Hu, Zhongyu Zhu, Shun Li, Yongqiang Deng, Yanling Wu, Nana Zhang, Vinita Puri, Chunyu Wang, Peng Zou, Cheng Lei, Xiaolong Tian, Yulu Wang, Qi Zhao, Wei Li, Ponraj Prabakaran, Yang Feng, Jane Cardosa, Chengfeng Qin, Xiaohui Zhou, Dimiter S. Dimitrov & Tianlei Ying. (2019) A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III. PLOS Pathogens 15:6, pages e1007836.
Crossref
Chenjian Gu, Shuai Tao, Kongying Hu, Lijun Ming, Mengjun Luo, Huimin Guo, Yu Su, Jing Liu & Youhua Xie. (2019) Establishment of an reporter system for screening HBx-targeting molecules. Acta Biochimica et Biophysica Sinica 51:4, pages 431-440.
Crossref
Cheng Li, Yang Wang, Tiantian Liu, Matthias Niklasch, Ke Qiao, Sarah Durand, Li Chen, Mifang Liang, Thomas F. Baumert, Shuping Tong, Michael Nassal, Yu-Mei Wen & Yong-Xiang Wang. (2019) An E. coli-produced single-chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion. Antiviral Research 162, pages 118-129.
Crossref
Yu-mei Wen & Yan Shi. 2019. Fc Mediated Activity of Antibodies. Fc Mediated Activity of Antibodies 95 118 .
Xiaodan Cai, Weihao Zheng, Shaokun Pan, Shengyuan Zhang, Youhua Xie, Haitao Guo, Guoxin Wang, Zigang Li & Ming Luo. (2017) A virus-like particle of the hepatitis B virus preS antigen elicits robust neutralizing antibody and T cell responses in mice. Antiviral Research.
Crossref
Georgina Salazar, Ningyan Zhang, Tong-Ming Fu & Zhiqiang An. (2017) Antibody therapies for the prevention and treatment of viral infections. npj Vaccines 2:1.
Crossref
Jiaqian Pan, Shuangmei Tong, Lei Kang & Jing Tang. (2016) New anti-hepatitis B virus drugs under development and evaluation. Current Opinion in Infectious Diseases 29:6, pages 632-638.
Crossref
Jisu Li, Li Zong, Camille Sureau, Luke Barker, Jack R. Wands & Shuping Tong. (2016) Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor. Journal of Virology 90:18, pages 8302-8313.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.